- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.11. | NT PHARMA (01011): CHANGES OF (1) COMPANY SECRETARY, (2) AUTHORISED REPRESENTATIVE AND (3) AGENT FOR THE ACCEPTANCE OF SERVICE OF PROCESS AND NOTICES ... | - | HKEx | ||
| 24.11. | NT PHARMA (01011): SUPPLEMENTAL ANNOUNCEMENT TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2024 AND INTERIM REPORT FOR THE SIX MONTHS ENDED 30 JUNE ... | 1 | HKEx | ||
| 17.10. | NT PHARMA (01011): RESIGNATION OF (1) COMPANY SECRETARY, (2) AUTHORISED REPRESENTATIVE AND (3) AGENT FOR THE ACCEPTANCE OF SERVICE OF PROCESS AND NOTICES ... | 1 | HKEx | ||
| 17.10. | NT PHARMA (01011): UPDATE IN RELATION TO THE DISCLAIMER OF OPINION ON GOING CONCERN SET OUT IN THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2024 | 1 | HKEx | ||
| 05.09. | NT PHARMA (01011): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER | - | HKEx | ||
| 05.09. | NT PHARMA (01011): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDER | - | HKEx | ||
| 05.09. | NT PHARMA (01011): INTERIM REPORT 2025 | 1 | HKEx | ||
| 19.08. | NT PHARMA (01011): INSIDE INFORMATION AND RESUMPTION OF TRADING | 1 | HKEx | ||
| CHINA NT PHARMA Aktie jetzt für 0€ handeln | |||||
| 19.08. | NT PHARMA (01011): TRADING HALT | - | HKEx | ||
| 18.08. | NT PHARMA (01011): CHANGE OF ADDRESS OF THE PRINCIPAL PLACE OF BUSINESS AND HEADQUARTERS | 1 | HKEx | ||
| 08.08. | NT PHARMA (01011): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 | - | HKEx | ||
| 30.07. | NT PHARMA (01011): VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE | 2 | HKEx | ||
| 29.07. | NT PHARMA (01011): DATE OF BOARD MEETING | 1 | HKEx | ||
| 30.06. | NT PHARMA (01011): DELAY IN DESPATCH OF CIRCULAR | - | HKEx | ||
| 30.06. | NT PHARMA (01011): TERMS OF REFERENCE OF NOMINATION COMMITTEE | 1 | HKEx | ||
| 30.06. | NT PHARMA (01011): CHANGE IN COMPOSITION OF BOARD COMMITTEE | - | HKEx | ||
| 30.06. | NT PHARMA (01011): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | 1 | HKEx | ||
| 30.06. | NT PHARMA (01011): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 30 JUNE 2025 | - | HKEx |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,940 | +0,13 % | Aurora Cannabis Inc (3): Aurora Cannabis's MedReleaf adds Leafio as wholesaler | ||
| CANOPY GROWTH | 0,981 | -0,71 % | Canopy USA: Wana Brands Launches THC Gummies in Switzerland Through Pioneering Pilot Program | Wana Brands, North America's leading edibles provider and a subsidiary of Canopy USA LLC ("Canopy USA"), announced today that the brand is launching its premium gummies in Zürich, Switzerland as... ► Artikel lesen | |
| TILRAY BRANDS | 6,285 | -0,24 % | XETR ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS88688T1007 Tilray Brands Inc. 01.12.2025 US88688T2096 Tilray Brands Inc. 02.12.2025 Tausch 10:1 ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Appoints New Director to Board | Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Digicann Ventures Inc. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis... ► Artikel lesen | |
| SINOPHARM | 2,272 | +0,40 % | SINOPHARM (01099): FORM OF PROXY FOR EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, 19 DECEMBER 2025 | ||
| INDIVA | 0,016 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.06.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 20.06.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.06.2025.ISIN NameCA45580J1012 INDIVA... ► Artikel lesen | |
| CSPC PHARMA | 0,847 | -1,47 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - GLP-1/GIP RECEPTOR DUAL-BIASED AGONIST POLYPEPTIDE INJECTION (SYH2069 INJECTION) OBTAINS CLINICAL TRIAL ... | ||
| ORAMED PHARMACEUTICALS | 2,320 | +0,04 % | Oramed Pharmaceuticals Inc.: Oramed Reports Fiscal Third Quarter 2025 Financial Results | Strong Nine-Month Performance Driven by Strategic Investment Portfolio; Total Assets Increase 42% to $220.5 Million
NEW YORK, Nov. 17, 2025 /PRNewswire/ --... ► Artikel lesen | |
| ADASTRA | 0,104 | +0,97 % | Adastra Holdings Ltd.: Adastra Holdings Announces Completion of Sale of Subsidiaries | Langley, British Columbia--(Newsfile Corp. - October 15, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the "Company") announces that it has completed the sale of all of the issued and outstanding... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 19,670 | -2,62 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update | Reported Q3 2025 Total Revenues of $148.4 Million, Driven by Continued FIRDAPSE® Growth, Strong AGAMREE® Uptake and Growth, and Continued Demand for FYCOMPA® Raising Full-Year 2025 Total Revenue Guidance... ► Artikel lesen | |
| METRIOPHARM | - | - | MetrioPharm gains orphan drug status from EMA for MP1032 | ||
| BAYER | 33,395 | -0,68 % | Pharmariese im Rallyemodus: Bayer-Aktie im boerse.de-Check | Die Bayer-Aktie sorgte vergangene Woche endlich wieder für positive Schlagzeilen. Nach einem langen Tief und mehreren vergeblichen Anläufen hat das Papier die psychologisch wichtige Marke von 30 Euro... ► Artikel lesen | |
| MERCK KGAA | 120,85 | +1,21 % | AKTIE IM FOKUS: Erholungsversuch Merck KGaA geht weiter - Sinneswandel bei Exane | FRANKFURT (dpa-AFX) - Die Aktien von Merck KGaA haben am Dienstagabend nach dem Ende des Xetra-Hauptgeschäfts Anlauf auf eine Charthürde genommen. Der Kurs kletterte auf der Handelsplattform Tradegate... ► Artikel lesen | |
| NOVO NORDISK | 41,305 | +0,15 % | JEFFERIES stuft NOVO NORDISK auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Novo Nordisk von 290 auf 270 dänische Kronen gesenkt und die Einstufung auf "Underperform" belassen. Auch nach dem deutlichen... ► Artikel lesen | |
| HARROW | 45,750 | -2,18 % | Harrow, Inc.: Harrow Health, Inc. Announces Closing of Acquisition of Melt Pharmaceuticals | NASHVILLE, Tenn., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the... ► Artikel lesen |
Das Unternehmen CHINA NT PHARMA GROUP CO LTD kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHINA NT PHARMA GROUP CO LTD finden Sie auf Wallstreet Online.